Development and Assessment of Lipidic Nanoemulsions Containing Sodium Hyaluronate and Indomethacin

被引:0
作者
Ibtissem Guermech
Mohamed Ali Lassoued
Amal Abdelhamid
Souad Sfar
机构
[1] University of Monastir,Laboratory of Chemical, Galenic and Pharmacological Development of Drugs (LR12ES09), Faculty of Pharmacy of Monastir
来源
AAPS PharmSciTech | / 20卷
关键词
sodium hyaluronate; indomethacin; nanoemulsion; Box–Behnken design; antioxidant activity; anti-inflammatory activity;
D O I
暂无
中图分类号
学科分类号
摘要
The present work attempts to develop and optimize the formula of a lipidic nanoemulsion (NE) containing sodium hyaluronate (HNa) and indomethacin (Ind) as HNa–Ind for enhanced transdermal antiarthritic activity. NEs were prepared by the spontaneous emulsification method and characterized by Fourier-transform infrared (FTIR) spectroscopy. The composition of the optimal formulation was statistically optimized using Box–Behnken experimental design method with three independent factors and was characterized for particle size, polydispersity index, and percent transmittance. The selected formula was tested for its in vitro antioxidant activity and in vivo anti-inflammatory activity. The optimized HNa–Ind NE formula was characterized and displayed a particle size of 12.87 ± 0.032 nm, polydispersity index of 0.606 ± 0.082, and 99.4 ± 0.1 percentage of transmittance. FTIR showed no interaction between HNa and Ind as a physical mixture. In addition, the optimized HNa–Ind NE was able to preserve the antioxidant ability of the two drugs, as evidenced through a 2,2-diphenyl-1-picrylhydrazyl (DPPH) inhibition assay used to assess free radical scavenging ability. The cell viability was increased while the free radical scavenging activity was decreased (94.28% inhibition at higher concentrations compared with vitamin C as a reference with an inhibition of 100%). Moreover, the pharmacological anti-inflammatory potential of the optimized HNa–Ind NE formulation was assessed using an in vivo model. Compared with reference drugs (ibuprofen gel 5%), the remarkable activity of the optimized formulation was established using xylene-induced ear edema in mice model, in which the inflamed region reduced by 92.5% upon treatment. The optimized HNa–Ind NE formulation showed considerably higher skin permeation and drug deposition capability compared with the HNa–Ind solution. HNa–Ind NE was demonstrated to be a successful carrier with enhanced antioxidant and anti-inflammatory potential while showing better skin penetration, thus being a promising vehicle for transdermal drug delivery.
引用
收藏
相关论文
共 37 条
  • [1] Development and Assessment of Lipidic Nanoemulsions Containing Sodium Hyaluronate and Indomethacin
    Guermech, Ibtissem
    Lassoued, Mohamed Ali
    Abdelhamid, Amal
    Sfar, Souad
    AAPS PHARMSCITECH, 2019, 20 (08)
  • [2] Formulation Development and Evaluation of the Therapeutic Efficacy of Brinzolamide Containing Nanoemulsions
    Mahboobian, Mohammad Mehdi
    Seyfoddin, Ali
    Rupenthal, Ilva D.
    Aboofazeli, Reza
    Foroutan, Seyed Mohsen
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (03): : 847 - 857
  • [3] Efficacy of an experimental toothpaste containing sodium bicarbonate, sodium hyaluronate and sodium fluoride on gingivitis
    Axe, Alyson
    Patel, Nisha
    Qaqish, Jimmy
    Ling, Martin R.
    Araga, Mako
    Parkinson, Charlie
    Goyal, Chaju Ram
    BMC ORAL HEALTH, 2024, 24 (01)
  • [4] Efficacy of an experimental toothpaste containing sodium bicarbonate, sodium hyaluronate and sodium fluoride on gingivitis
    Alyson Axe
    Nisha Patel
    Jimmy Qaqish
    Martin R. Ling
    Mako Araga
    Charlie Parkinson
    Chaju Ram Goyal
    BMC Oral Health, 24
  • [5] Herpes Zoster Development After Intraarticular Sodium Hyaluronate Injection
    Semih, Tatlican
    Bilgen, Oktay
    Cemile, Eren
    Fatma, Eskioglu
    JOURNAL OF MUSCULOSKELETAL PAIN, 2009, 17 (01): : 86 - 89
  • [6] In vitro Staphylococcus epidermidis growth in some viscoelastic substances containing sodium hyaluronate
    Gallenga, PE
    Mastropasqua, L
    Carpineto, P
    Ciancaglini, M
    Falconio, G
    Catamo, G
    Costagliola, C
    Piccolomini, R
    OPHTHALMOLOGICA, 1998, 212 (03) : 184 - 187
  • [7] Formulation development of ethosomes containing indomethacin for transdermal delivery
    Sakdiset, Pajaree
    Amnuaikit, Thanaporn
    Pichayakorn, Wiwat
    Pinsuwan, Sirirat
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 52 : 760 - 768
  • [8] Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment
    Kar, M.
    Ince, I.
    Yildirim, C.
    Donmez, D. Burukoglu
    Karasulu, Y.
    Cingi, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 : 65 - 71
  • [9] ASSESSMENT OF THE MOISTURIZING POTENTIAL OF A TWO-PHASE TOPICAL CARE PRODUCT CONTAINING VEGETABLE OILS, GLYCERIN, PANTHENOL, AND SODIUM HYALURONATE - A PRELIMINARY STUDIES
    Balwierz, Radoslaw
    Biernat, Pawel
    Schafer, Natalia
    Marciniak, Dominik
    Krzeszewska-Zareba, Anna
    Skotnicka-Graca, Urszula
    Kurek-Gorecka, Anna
    ACTA POLONIAE PHARMACEUTICA, 2022, 79 (02): : 245 - 254
  • [10] Design and evaluation of mucoadhesive oral films containing sodium hyaluronate using multivariate data analysis
    Walicova, Veronika
    Gajdziok, Jan
    Pavlokova, Sylvie
    Vetchy, David
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2017, 22 (02) : 229 - 236